Skip to main content
profile image
Selected Works of Michael Germain
Contribution to Book
Update on anemia and kidney disease
All Scholarly Works
  • Kiran Goli, MD, Baystate Health
  • Arkadiy Pinkashov, MD, Baystate Health
  • Daniel Landry, MD, Baystate Health
  • Michael Germain, MD, Baystate Health
Document Type
Book Chapter
Publication Date
4-1-2013
Disciplines
Abstract

In this chapter we will discuss the emerging issues and controversies in anemia management in Chronic Kidney Disease (CKD). The normal physiologic control of erythropoiesis and the pathophysiology in CKD will be discussed specifically with regards to current problems with dosing protocols and novel approaches to improve these issues. The causes and treatments of resistance to erythropoiesis stimulating agents (ESAs), hemoglobin "cycling" and variability will be addressed. The emerging safety concerns with ESAs and novel ESAs that may be safer will be discussed.

Citation Information
Goli, K, Pinkhasov, A, Landry, D, Chait, Y, Horowitz, J, Hollot, C, Shrestha, R, Germain, M. Update on anemia and kidney disease. In Fadem S: Issues in Dialysis, Hauppauge NY, Nova Science Publishers Inc., 2013.